APOE and Alzheimer disease: It has been shown that carriers of apolipoprotein E4 (APOE4) (ε3/ε4 or ε4/ε4), an identified genetic risk factor for AD, show a higher BBB permeability in the medial temporal lobe and hippocampus compared with non-carriers, even when cognitively healthy [21].